International Journal of STD & AIDS > Volume 19, Number 11 > Pp. 786-788

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kumarasamy, N Articles by Ahilasamy, N Search for Related Content PubMed PubMed Citation Social Bookmarking                      What's this?

Case reports

Regression of Kaposi's sarcoma lesions following highly active antiretroviral therapy in an HIV-infected patient

N Kumarasamy MBBS PhD ^* , K K Venkatesh BA , B Devaleenol MBBS DLO ^*, S Poongulali MBBS DGO ^* and N Ahilasamy MS FRCS 

^* YRG Centre for AIDS Research and Education, Chennai, India; Brown University Medical School, Providence, RI, USA; Ahilasamy ENT Centre, Chennai, India

Correspondence to: Dr N Kumarasamy, YRG Centre for AIDS Research and Education, Voluntary Health Services, Taramani, Chennai 600113, India Email: kumarasamy{at}yrgcare.org

This case report documents that highly active antiretroviral therapy (HAART) can lead to the regression of Kaposi's sarcoma (KS) lesions in the auditory canal of an HIV-infected male from Chennai, India. In resource-limited settings where administering anti-KS chemotherapeutic agents may not be feasible, HAART alone can be an option in HIV-infected individuals with KS.

Key Words: India • HIV • AIDS • HAART • Kaposi sarcoma

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?